Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Chemodivergent Synthesis of Fused Indole and Spirocyclic Indoline Through Solo-Coordination-Vacant Ir(III) Pincer Complex-Catalyzed Acylnitrenoid Transfer.

Created on 29 Sep 2026

Authors

Yun-Zhe Wang, Cheng-Yu Gu, Yuan-Liang Zou, Chuanyong Wang, Jiajia Ma

Published in

Chemistry (Weinheim an der Bergstrasse, Germany). Pages e71746. Sep 29, 2026. Epub Sep 29, 2026.

Abstract

Despite the medicinal importance of fused indoles and spirocyclic indolines, a divergent synthesis of these two frameworks from identical starting materials remains elusive. Herein, we report a solo-coordination-vacant Ir(III) pincer complex-catalyzed chemodivergent annulation of indole-derived dioxazolones that selectively constructs either scaffold by simply modulating reaction conditions. The transformation proceeds via a common iridium-nitrenoid intermediate that diverges through either a 1,2-alkyl migration or hydride-transfer pathway, delivering both classes of products with high efficiency. Notably, the spirocyclization pathway operates at an exceptionally low catalyst loading of 0.01 mol%, affording a remarkable turnover number up to 6800. This work not only fills the gap in divergent access to these two medicinally relevant heterocycles but also demonstrates the synthetic potential of nitrenoid intermediates in enabling tunable indole dearomatization.

PMID:
42806954
Bibliographic data and abstract were imported from PubMed on 29 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement